ATHIRA PHARMA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.925 USD | +0.26% |
|
-7.42% | -20.37% |
Chart calendar Athira Pharma, Inc.
d888938494f345f21c6743911eb.-oGuOuN0szPjWB2zTz6W5GmRryxdHmC-1Ks3-EvmlGY.sff8XocR_16OMVWKKnr6kwLHl0cfVy7msJJ0gXyf0wDD1NYCqDLbYJM2VA~d8374402d77e120bb179882a4ec986a4
Upcoming events on Athira Pharma, Inc.
Past events on Athira Pharma, Inc.
| 2024-04-17 08:30 pm | American Academy of Neurology Meeting |
| 2024-03-09 01:00 pm | AD/PD Alzheimers and Parkinsons Diseases International Conference - Abstract Number:#0546 |
| 2024-03-09 01:00 pm | AD/PD Alzheimers and Parkinsons Diseases International Conference - Abstract Number:#0209 |
| 2024-03-08 04:00 am | AD/PD Alzheimers and Parkinsons Diseases International Conference - Abstract Number:#1243 |
| 2024-03-08 04:00 am | AD/PD Alzheimers and Parkinsons Diseases International Conference - Abstract Number:#1757 |
| 2024-03-07 01:00 pm | AD/PD Alzheimers and Parkinsons Diseases International Conference - Abstract Number:#0465 |
| 2024-03-06 04:00 am | AD/PD Alzheimers and Parkinsons Diseases International Conference - Abstract Number:#1857 |
| 2024-02-22 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-25 10:00 am | Sequire Investor Summit |
| 2023-12-07 06:15 am | Motor Neurone Disease Association International Symposium |
| 2023-12-06 12:15 pm | Sidoti December Small-Cap Conference |
| 2023-11-16 08:30 am | Jefferies London Healthcare Conference - Fireside Chat |
| 2023-11-09 04:06 pm | Q3 2023 Earnings Release |
| 2023-10-12 08:30 am | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 2023-10-08 | JonesTrading Healthcare Summit |
| 2023-10-03 | Northeast ALS Consortium Meeting - Poster No: 146 |
| 2023-10-03 10:00 am | Goldman Sachs Alzheimer Disease Day |
| 2023-09-26 10:30 am | Cantor Global Healthcare Conference |
| 2023-08-10 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-19 02:45 am | Alzheimer Association International Conference - Poster Number: 79759 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,06 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -20,0 -31,4 36.31% | -63,5 -63,4 -0.15% | -93,2 -94,7 1.65% | 0,00 0,00 - | -134 |
|
EBIT Million USD | Released Forecast Spread | -5,45 | -20,0 -25,5 21.47% | -64,0 -66,8 4.22% | -94,0 -96,7 2.81% | -127 -135 6.01% | -130 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -20,0 -24,5 18.6% | -54,9 -61,4 10.66% | -95,6 -91,0 -5.12% | -118 -128 8% | -126 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -20,0 -24,8 19.43% | -54,9 -60,1 8.78% | -95,6 -90,9 -5.23% | -118 -127 7.33% | -124 |
|
EPS USD | Released Forecast Spread | -1,43 | -1,67 -1,83 8.58% | -1,49 -1,62 8.21% | -2,53 -2,40 -5.24% | -3,09 -3,34 7.39% | -2,68 |
| Announcement Date | 24/07/20 | 25/03/21 | 24/03/22 | 23/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,8 -21,6 13.17% | -23,4 -22,9 -2.13% | -23,6 -25,1 6.28% | -24,1 -24,4 1.08% | -22,9 -25,6 10.58% | -29,8 -24,9 -19.73% | -31,6 -30,9 -2.48% | -35,0 -33,4 -4.89% | -30,6 -38,7 20.91% | -32,0 | -32,4 | -32,5 | -30,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,3 -22,9 28.65% | -21,0 -22,1 5.24% | -24,3 -23,8 -2.45% | -20,2 -23,8 15.27% | -30,1 -25,5 -18.27% | -27,8 -24,9 -11.73% | -29,6 -30,4 2.74% | -33,0 -32,3 -2.09% | -27,3 -37,9 28.08% | -29,6 | -30,0 | -30,3 | -27,0 |
|
Net income Million USD | Released Forecast Spread | -16,3 -22,9 28.65% | -21,0 -22,3 5.94% | -24,3 -24,0 -1.39% | -20,2 -24,2 16.41% | -30,1 -24,6 -22.45% | -27,8 -24,9 -11.86% | -29,6 -30,4 2.74% | -33,0 -32,0 -3.04% | -27,3 -37,9 28.08% | -30,3 | -31,1 | -31,8 | -30,0 |
|
EPS USD | Released Forecast Spread | -0,37 -0,57 35.46% | -0,56 -0,58 2.61% | -0,65 -0,65 0.61% | -0,53 -0,65 18.21% | -0,79 -0,66 -20.06% | -0,73 -0,64 -14.96% | -0,78 -0,77 -1.04% | -0,87 -0,81 -6.88% | -0,71 -0,96 26.17% | -0,80 | -0,81 | -0,82 | -0,64 |
| Announcement Date | 24/03/22 | 12/05/22 | 15/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 22/02/24 | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Athira Pharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATHA Stock
- Calendar Athira Pharma, Inc.
